Cargando…
Interstitial Pregnancy Treated with Mifepristone and Methotrexate with High Serum β-hCG Level in a Patient Wishing to Preserve Fertility: Time to Define Standardized Criteria for Medical/Surgical Therapy?
Interstitial pregnancy (IP) accounts for 2% of all ectopic pregnancies and has a mortality rate of 2–2.5%. The diagnosis is made by a transvaginal ultrasound and the treatment can be medical or surgical. We report the case of a 36-year-old primigravida who was 6 + 5 weeks pregnant, diagnosed with in...
Autores principales: | Sorrentino, Felice, Vasciaveo, Lorenzo, De Feo, Vincenzo, Zanzarelli, Erika, Grandone, Elvira, Stabile, Guglielmo, Nappi, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9516977/ https://www.ncbi.nlm.nih.gov/pubmed/36141736 http://dx.doi.org/10.3390/ijerph191811464 |
Ejemplares similares
-
Conservative Treatment of Interstitial Ectopic Pregnancy with the Combination of Mifepristone and Methotrexate: Our Experience and Review of the Literature
por: Stabile, Guglielmo, et al.
Publicado: (2020) -
Biological functions of hCG and hCG-related molecules
por: Cole, Laurence A
Publicado: (2010) -
Interstitial Ectopic Pregnancy: The Role of Mifepristone in the Medical Treatment
por: Stabile, Guglielmo, et al.
Publicado: (2021) -
Validation of (125)I-hCG as a marker for elimination of hCG and stability of (125)I-hCG after in vivo injection in humans
por: Christensen, T B, et al.
Publicado: (1999) -
Multidosing Intramuscular Administration of Methotrexate in Interstitial Pregnancy With Very High Levels of β-hCG: A Case Report and Review of the Literature
por: Conti, Valeria, et al.
Publicado: (2018)